NEW! Deal Performance Analytics
PharmaDeals Corp-METRx provides vital company metrics that enable comparison of the top 12 Pharmaceutical Companies deal strategies and activities. Covering overall licensing and M&A activity (short and long term), therapeutic focus, plus deal activity relative to R&D spend, this is a key resource for all executives and analysts within biotechnology, pharmaceutical and the financial services sectors.

Updated monthly, PharmaDeals Corp-METRx provides key metrics on the relative strengths and weaknesses of the world’s top 12 pharmaceutical companies. Delivered in a concise and instantly accessible online format, this new publication provides an essential look-up for key facts about how major pharmaceutical companies deal making activities vary, the impact this has on their peer group ranking and how this evolves with time.
Key Learnings:
  • Which of the top 12 is the deal making leader for different therapeutic areas.
  • Who is striking the most deals in the short term.
  • How do they rank in terms of their long term deal strategies.
  • Who are the most acquisitive in the M&A sector
  • How are these companies balancing internal and external pipeline filling.
Download FREE Sample Edition
Complete the form, and we will email you a link to the November 2011 METRx Reports and the Monthly Review Article
First Name:
Last Name:
Company:
Email:
Receive Vital Deal Making Performance Analysis on Top Pharma.

For subscription information, please contact us now on: enquiries@pharmadeals.net

Or telephone +44(0)1865 332700

Bookmarks

Bookmark PharmaDeals through one of these social networks.

PharmaDeals Corp-METRx
ISSN 2047-7007

Published online
4 quarterly issues per year
Who should subscribe:
Analysts, M&A and corporate finance professionals in investment banks, hedge funds, large cap advisory and asset management firms.

Business development and competitive intelligence professionals, chief executives and other senior managers within pharmaceutical and biotechnology companies.

Published by
PharmaDeals Ltd, an IMS Health company

Pentonville Road
London
N1 9JY, UK


All enquires, including subscription information and permission requests:
Email: pdenquiries@@uk.imshealth.com
© IMS PharmaDeals Ltd 2013
All Rights Reserved. All users are expected to adhere to published Terms and Conditions for use. The contents of this publication is protected by international laws, and no part of this publication may be photocopied, transmitted or reproduced in any form.